How much is Convergent Therapeutics worth in 2026?

Convergent Therapeutics has a current valuation of $280.0M based on their Early Stage VC round and secondary market data.

How much funding has Convergent Therapeutics raised?

Convergent Therapeutics has raised $130.0M in total funding across 1 funding rounds.

Convergent Therapeutics

Drug DiscoveryWebsite

Convergent Therapeutics valuation and funding history | Last updated: September 24, 2024 | 1 funding rounds

Current Valuation

$280.0M

As of September 24, 2024

Total Funding Raised

$130.0M

Across 1 round

Last Round

Early Stage VC

$40.0M

Last Funding

Sep 2024

Funding date

Capital Efficiency

2.15x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 1, 2023	Early Stage VC (Series A)	$90.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Convergent Therapeutics is currently valued at $280.0M as of September 24, 2024. The company has raised a total of $130.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 2.15x, Convergent Therapeutics has achieved a valuation that is 2.15 times the total capital raised.

Track Convergent Therapeutics Valuation Updates

Get notified when Convergent Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Convergent Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Convergent Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Convergent Therapeutics Worth in 2026?

Convergent Therapeutics is a leading private company in the Drug Discovery sector. Track Convergent Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Convergent Therapeutics Valuation is Determined

Private company valuations like Convergent Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.